A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

COMPLETED

Memorial Sloan Kettering Cancer Center, New York

RECRUITING

National Institutes of Health Clinical Center, Bethesda

COMPLETED

Mount Sinai Comprehensive Cancer Center, Miami Beach

COMPLETED

Sarah Cannon Research Institute at Florida Cancer Specialists, Sarasota

RECRUITING

Tennessee Oncology, Nashville

COMPLETED

OSU Wexner Medical Center, Columbus

COMPLETED

University of Cincinnati Medical Center, Cincinnati

RECRUITING

The University of Chicago Medical Center, Chicago

COMPLETED

Baylor University Medical Center, Dallas

RECRUITING

MD Anderson Cancer Center, Houston

RECRUITING

Sarah Cannon Research Institute at Colorado Blood Cancer Institute, Denver

RECRUITING

Huntsman Cancer Institute, University of Utah, Salt Lake City

RECRUITING

City of Hope, Duarte

COMPLETED

University of California Irvine, Orange

COMPLETED

University of California San Francisco Medical Center, San Francisco

COMPLETED

Swedish Cancer Institute, Seattle